Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
Radiology. 1996;198(2):365-70 - PMID: 8596833
An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties.
Bioconjug Chem. 1996;7(1):144-9 - PMID: 8742003
Magnetically labeled secretin retains receptor affinity to pancreas acinar cells.
Bioconjug Chem. 1996;7(3):311-6 - PMID: 8816953
Drug delivery to lymphatic tissue.
Crit Rev Ther Drug Carrier Syst. 1996;13(1-2):57-84 - PMID: 8853959
MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
AJNR Am J Neuroradiol. 1996;17(3):411-8 - PMID: 8881233
Can gadolinium be safely given in renal failure?
AJR Am J Roentgenol. 1996;167(1):278-9 - PMID: 8659405
Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
Magn Reson Imaging. 1996;4(1):53-60 - PMID: 8673716
An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents.
Magn Reson Imaging. 1996;13(7):991-1002 - PMID: 8583878
Targeted contrast agents in MR imaging.
Magn Reson Imaging. 1996;4(1):171-84 - PMID: 8673713
[Development and experimental use of receptor-specific MR contrast media]
Radiologe. 1996;36(2):153-63 - PMID: 8867433
[Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media]
Z Lymphol. 1996;20(1):15-20 - PMID: 8768044
11
